{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:57:43Z","timestamp":1774025863641,"version":"3.50.1"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12868-015-0211-1","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T19:44:30Z","timestamp":1445629470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Neuronal response in Alzheimer\u2019s and Parkinson\u2019s disease: the effect of toxic proteins on intracellular pathways"],"prefix":"10.1186","volume":"16","author":[{"given":"Shohreh","family":"Majd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Power","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh J. M.","family":"Grantham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"issue":"9","key":"211_CR1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s00018-003-3096-6","volume":"60","author":"VN Uversky","year":"2003","unstructured":"Uversky VN. Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go? Cell Mol Life Sci. 2003;60(9):1852\u201371.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"211_CR2","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","volume":"14","author":"M Stefani","year":"2013","unstructured":"Stefani M, Rigacci S. Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. Int J Mol Sci. 2013;14(6):12411\u201357.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"211_CR3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0168-9525(98)01559-5","volume":"14","author":"A Kakizuka","year":"1998","unstructured":"Kakizuka A. Protein precipitation: a common etiology in neuro-degenerative disorders? Trends Genet. 1998;14(10):396\u2013402.","journal-title":"Trends Genet"},{"issue":"11","key":"211_CR4","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1038\/35041139","volume":"2","author":"RR Kopito","year":"2000","unstructured":"Kopito RR, Ron D. Conformational disease. Nat Cell Biol. 2000;2(11):E207\u20139.","journal-title":"Nat Cell Biol"},{"issue":"20","key":"211_CR5","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MB, Kugler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, et al. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J. 2009;28(20):3256\u201368.","journal-title":"EMBO J"},{"issue":"7353","key":"211_CR6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature10099","volume":"474","author":"MB Borgia","year":"2011","unstructured":"Borgia MB, Borgia A, Best RB, Steward A, Nettels D, Wunderlich B, Schuler B, Clarke J. Single-molecule fluorescence reveals sequence-specific misfolding in multidomain proteins. Nature. 2011;474(7353):662\u20135.","journal-title":"Nature"},{"issue":"1","key":"211_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2011.02387.x","volume":"270","author":"E Norrby","year":"2011","unstructured":"Norrby E. Prions and protein-folding diseases. J Intern Med. 2011;270(1):1\u201314.","journal-title":"J Intern Med"},{"issue":"1","key":"211_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbadis.2004.08.004","volume":"1739","author":"M Stefani","year":"2004","unstructured":"Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta. 2004;1739(1):5\u201325.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"211_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","volume":"27","author":"KF Winklhofer","year":"2008","unstructured":"Winklhofer KF, Tatzelt J, Haass C. The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J. 2008;27(2):336\u201349.","journal-title":"EMBO J"},{"issue":"1","key":"211_CR10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1021\/bi201745g","volume":"51","author":"A Abelein","year":"2012","unstructured":"Abelein A, Bolognesi B, Dobson CM, Graslund A, Lendel C. Hydrophobicity and conformational change as mechanistic determinants for nonspecific modulators of amyloid beta self-assembly. Biochemistry. 2012;51(1):126\u201337.","journal-title":"Biochemistry"},{"issue":"6","key":"211_CR11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"AM Blokhuis","year":"2013","unstructured":"Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125(6):777\u201394.","journal-title":"Acta Neuropathol"},{"key":"211_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","volume":"924","author":"DJ Selkoe","year":"2000","unstructured":"Selkoe DJ. Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci. 2000;924:17\u201325.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"211_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1107-8","volume":"125","author":"S Kumar","year":"2013","unstructured":"Kumar S, Wirths O, Theil S, Gerth J, Bayer TA, Walter J. Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol. 2013;125(5):699\u2013709.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"211_CR14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0896-6273(00)80406-7","volume":"19","author":"PT Lansbury Jr","year":"1997","unstructured":"Lansbury PT Jr. Structural neurology: are seeds at the root of neuronal degeneration? Neuron. 1997;19(6):1151\u20134.","journal-title":"Neuron"},{"issue":"40","key":"211_CR15","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"2","key":"211_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2990.1999.00164.x","volume":"25","author":"E Storey","year":"1999","unstructured":"Storey E, Cappai R. The amyloid precursor protein of Alzheimer\u2019s disease and the Abeta peptide. Neuropathol Appl Neurobiol. 1999;25(2):81\u201397.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"211_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","volume":"483","author":"J Nunan","year":"2000","unstructured":"Nunan J, Small DH. Regulation of APP cleavage by alpha-, beta- and gamma- secretases. FEBS Lett. 2000;483(1):6\u201310.","journal-title":"FEBS Lett"},{"issue":"8","key":"211_CR18","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.0308655100","volume":"101","author":"A Ho","year":"2004","unstructured":"Ho A, Sudhof TC. Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Natl Acad Sci USA. 2004;101(8):2548\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"211_CR19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1471-4159.2005.03563.x","volume":"96","author":"D Schubert","year":"2006","unstructured":"Schubert D, Klar A, Park M, Dargusch R, Fischer WH. F-spondin promotes nerve precursor differentiation. J Neurochem. 2006;96(2):444\u201353.","journal-title":"J Neurochem"},{"issue":"2","key":"211_CR20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0896-6273(00)00124-0","volume":"28","author":"A Kamal","year":"2000","unstructured":"Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 2000;28(2):449\u201359.","journal-title":"Neuron"},{"issue":"5","key":"211_CR21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1046\/j.1471-4159.1998.71051920.x","volume":"71","author":"GK Gouras","year":"1998","unstructured":"Gouras GK, Xu H, Jovanovic JN, Buxbaum JD, Wang R, Greengard P, Relkin NR, Gandy S. Generation and regulation of beta-amyloid peptide variants by neurons. J Neurochem. 1998;71(5):1920\u20135.","journal-title":"J Neurochem"},{"issue":"11","key":"211_CR22","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.5345-07.2008","volume":"28","author":"A Schneider","year":"2008","unstructured":"Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, Wouters F, Hell SW, Simons M. Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci. 2008;28(11):2874\u201382.","journal-title":"J Neurosci"},{"issue":"11","key":"211_CR23","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/MCB.05015-11","volume":"31","author":"T Sarajarvi","year":"2011","unstructured":"Sarajarvi T, Tuusa JT, Haapasalo A, Lackman JJ, Sormunen R, Helisalmi S, Roehr JT, Parrado AR, Makinen P, Bertram L, et al. Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. Mol Cell Biol. 2011;31(11):2326\u201340.","journal-title":"Mol Cell Biol"},{"issue":"31","key":"211_CR24","first-page":"1","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Huang T, Bu G, Xu H. Dysregulation of protein trafficking in neurodegeneration. Mol Neurodegenr. 2014;9(31):1\u20139.","journal-title":"Mol Neurodegenr."},{"issue":"39","key":"211_CR25","doi-asserted-by":"crossref","first-page":"34088","DOI":"10.1074\/jbc.M111.243907","volume":"286","author":"J Olah","year":"2011","unstructured":"Olah J, Vincze O, Virok D, Simon D, Bozso Z, Tokesi N, Horvath I, Hlavanda E, Kovacs J, Magyar A, et al. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein\/p25, beta-amyloid, and alpha-synuclein. J Biol Chem. 2011;286(39):34088\u2013100.","journal-title":"J Biol Chem"},{"issue":"11","key":"211_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0166-2236(00)01647-7","volume":"23","author":"DR Howlett","year":"2000","unstructured":"Howlett DR, Simmons DL, Dingwall C, Christie G. In search of an enzyme: the beta-secretase of Alzheimer\u2019s disease is an aspartic proteinase. Trends Neurosci. 2000;23(11):565\u201370.","journal-title":"Trends Neurosci"},{"issue":"41","key":"211_CR27","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, Ihara Y. gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009;29(41):13042\u201352.","journal-title":"J Neurosci"},{"issue":"5","key":"211_CR28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1471-4159.2005.03266.x","volume":"94","author":"JC Wiley","year":"2005","unstructured":"Wiley JC, Hudson M, Kanning KC, Schecterson LC, Bothwell M. Familial Alzheimer\u2019s disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. J Neurochem. 2005;94(5):1189\u2013201.","journal-title":"J Neurochem"},{"issue":"2","key":"211_CR29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1471-4159.1995.65020931.x","volume":"65","author":"J Davis-Salinas","year":"1995","unstructured":"Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE. Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem. 1995;65(2):931\u20134.","journal-title":"J Neurochem"},{"key":"211_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.brainres.2007.09.033","volume":"1185","author":"S Majd","year":"2007","unstructured":"Majd S, Rastegar K, Zarifkar A, Takhshid MA. Fibrillar beta-amyloid (Abeta) (1-42) elevates extracellular Abeta in cultured hippocampal neurons of adult rats. Brain Res. 2007;1185:321\u20137.","journal-title":"Brain Res"},{"issue":"4","key":"211_CR31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","volume":"165","author":"C Casas","year":"2004","unstructured":"Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, et al. Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol. 2004;165(4):1289\u2013300.","journal-title":"Am J Pathol"},{"issue":"3","key":"211_CR32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/ggi.12147","volume":"14","author":"K Yamamoto","year":"2014","unstructured":"Yamamoto K, Shimada H, Koh H, Ataka S, Miki T. Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer\u2019s disease. Geriatr Gerontol Int. 2014;14(3):716\u201323.","journal-title":"Geriatr Gerontol Int"},{"key":"211_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583598003400","volume":"31","author":"M Sunde","year":"1998","unstructured":"Sunde M, Blake CC. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys. 1998;31:1\u201339.","journal-title":"Q Rev Biophys"},{"key":"211_CR34","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1073\/pnas.95.23.13407","volume":"95","author":"TL Benzinger","year":"1998","unstructured":"Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. Propagating structure of Alzheimer\u2019s beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci USA. 1998;95:13407\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"211_CR35","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1021\/bi027378p","volume":"42","author":"R Tycko","year":"2003","unstructured":"Tycko R. Insights into the amyloid folding problem from solid-state NMR. Biochemistry. 2003;42:3151\u20139.","journal-title":"Biochemistry"},{"key":"211_CR36","doi-asserted-by":"crossref","first-page":"40810","DOI":"10.1074\/jbc.M205659200","volume":"277","author":"M Torok","year":"2002","unstructured":"Torok M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R. Structural and dynamic features of Alzheimer\u2019s A\u03b2 peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem. 2002;277:40810\u20135.","journal-title":"J Biol Chem"},{"key":"211_CR37","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.bbamem.2007.01.018","volume":"1768","author":"K Yanagisawa","year":"2002","unstructured":"Yanagisawa K. Role of gangliosides in Alzheimer\u2019s disease. Biochim Biophys Acta. 2002;1768:1943\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"211_CR38","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG Felice De","year":"2002","unstructured":"De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL. Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2002;282:11590\u2013601.","journal-title":"J Biol Chem"},{"key":"211_CR39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM Laferla","year":"2007","unstructured":"Laferla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer\u2019s disease. Nat Rev Neurosci. 2007;8:499\u2013509.","journal-title":"Nat Rev Neurosci"},{"key":"211_CR40","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","volume":"26","author":"CG Almeida","year":"2006","unstructured":"Almeida CG, Takahashi RH, Gouras GK. Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci. 2006;26:4277\u201388.","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"211_CR41","first-page":"81","volume":"22","author":"JT Huse","year":"2000","unstructured":"Huse JT, Doms RW. Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer\u2019s disease. Mol Neurobiol. 2000;22(1\u20133):81\u201398.","journal-title":"Mol Neurobiol"},{"issue":"Pt 11","key":"211_CR42","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/brain\/awl280","volume":"129","author":"HW Klafki","year":"2006","unstructured":"Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J. Therapeutic approaches to Alzheimer\u2019s disease. Brain. 2006;129(Pt 11):2840\u201355.","journal-title":"Brain"},{"issue":"20","key":"211_CR43","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1073\/pnas.90.20.9513","volume":"90","author":"AM Wertkin","year":"1993","unstructured":"Wertkin AM, Turner RS, Pleasure SJ, Golde TE, Younkin SG, Trojanowski JQ, Lee VM. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta- amyloid or A4 peptides. Proc Natl Acad Sci USA. 1993;90(20):9513\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"211_CR44","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol. 2002;161(5):1869\u201379.","journal-title":"Am J Pathol"},{"issue":"3","key":"211_CR45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mcn.2010.07.005","volume":"45","author":"X Alvira-Botero","year":"2010","unstructured":"Alvira-Botero X, Perez-Gonzalez R, Spuch C, Vargas T, Antequera D, Garzon M, Bermejo-Pareja F, Carro E. Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol Cell Neurosci. 2010;45(3):306\u201315.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"211_CR46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","volume":"56","author":"Q Liu","year":"2007","unstructured":"Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, Herz J, Muglia L, Bu G. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron. 2007;56(1):66\u201378.","journal-title":"Neuron"},{"key":"211_CR47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fphys.2012.00269","volume":"3","author":"C Spuch","year":"2012","unstructured":"Spuch C, Ortolano S, Navarro C. LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer\u2019s disease. Front Physiol. 2012;3:269.","journal-title":"Front Physiol"},{"issue":"47","key":"211_CR48","doi-asserted-by":"crossref","first-page":"20021","DOI":"10.1073\/pnas.0905686106","volume":"106","author":"K Takuma","year":"2009","unstructured":"Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, Sosunov A, McKhann G, Funatsu Y, Nakamichi N, et al. RAGE-mediated signalling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci USA. 2009;106(47):20021\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"211_CR49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nm0997-1021","volume":"3","author":"DG Cook","year":"1997","unstructured":"Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW. Alzheimer\u2019s Abeta(1-42) is generated in the endoplasmic reticulum\/intermediate compartment of NT2N cells. Nat Med. 1997;3(9):1021\u20133.","journal-title":"Nat Med"},{"issue":"2","key":"211_CR50","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1073\/pnas.96.2.742","volume":"96","author":"JP Greenfield","year":"1999","unstructured":"Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P, Xu H. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci USA. 1999;96(2):742\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"211_CR51","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1471-4159.1998.71041535.x","volume":"71","author":"S Sudoh","year":"1998","unstructured":"Sudoh S, Kawamura Y, Sato S, Wang R, Saido TC, Oyama F, Sakaki Y, Komano H, Yanagisawa K. Presenilin 1 mutations linked to familial Alzheimer\u2019s disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites. J Neurochem. 1998;71(4):1535\u201343.","journal-title":"J Neurochem"},{"issue":"5","key":"211_CR52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.14348\/molcells.2015.0034","volume":"38","author":"J Nah","year":"2015","unstructured":"Nah J, Yuan J, Jung YK. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells. 2015;38(5):381\u20139.","journal-title":"Mol Cells"},{"key":"211_CR53","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s11064-013-1082-4","volume":"38","author":"M UamekKozio","year":"2013","unstructured":"UamekKozio M, Furmaga-Jaboska W, Januszewski S, Brzozowska J, Scilewska M, Jaboski M, Pluta R. Neuronal autophagy: self-eating or self-cannibalism in Alzheimer\u2019s disease. Neurochem Res. 2013;38:1769\u201373.","journal-title":"Neurochem Res"},{"key":"211_CR54","doi-asserted-by":"crossref","first-page":"1006.e11","DOI":"10.1016\/j.neurobiolaging.2011.09.039","volume":"33","author":"SM Son","year":"2012","unstructured":"Son SM, Jung ES, Shin HJ, Byun J, Mook-Jung I. A\u03b2-induced formation of autophagosomes is mediated by RAGECaMKK \u03b2-AMPK signaling. Neurobiol Aging. 2012;33:1006.e11\u201323.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"211_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.2001.tb00376.x","volume":"11","author":"TA Bayer","year":"2001","unstructured":"Bayer TA, Wirths O, Majtenyi K, Hartmann T, Multhaup G, Beyreuther K, Czech C. Key factors in Alzheimer\u2019s disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 2001;11(1):1\u201311.","journal-title":"Brain Pathol"},{"issue":"17","key":"211_CR56","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.90.17.7951","volume":"90","author":"DT Loo","year":"1993","unstructured":"Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA. 1993;90(17):7951\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 1","key":"211_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3110001","volume":"311","author":"LL Versen","year":"1995","unstructured":"Versen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS. The toxicity in vitro of beta-amyloid protein. Biochem J. 1995;311(Pt 1):1\u201316.","journal-title":"Biochem J"},{"issue":"5","key":"211_CR58","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jocn.2003.12.007","volume":"11","author":"MS Parihar","year":"2004","unstructured":"Parihar MS, Hemnani T. Alzheimer\u2019s disease pathogenesis and therapeutic interventions. J Clin Neurosci. 2004;11(5):456\u201367.","journal-title":"J Clin Neurosci"},{"issue":"7","key":"211_CR59","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","volume":"93","author":"M Hoshi","year":"1996","unstructured":"Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, Saitoh Y, Ishiguro K, Hoshino T, Imahori K. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci USA. 1996;93(7):2719\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"211_CR60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","volume":"29","author":"RS Jope","year":"2004","unstructured":"Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29(2):95\u2013102.","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"211_CR61","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem. 2008;104(6):1433\u20139.","journal-title":"J Neurochem"},{"key":"211_CR62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnmol.2011.00045","volume":"4","author":"R Gomez-Sintes","year":"2011","unstructured":"Gomez-Sintes R, Hernandez F, Lucas JJ, Avila J. GSK-3 mouse models to study neuronal apoptosis and neurodegeneration. Front Mol Neurosci. 2011;4:45.","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"211_CR63","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","volume":"58","author":"JJ Pei","year":"1999","unstructured":"Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol. 1999;58(9):1010\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"211_CR64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s004010050513","volume":"92","author":"H Yamaguchi","year":"1996","unstructured":"Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I\/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. 1996;92(3):232\u201341.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"211_CR65","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3233\/JAD-142025","volume":"44","author":"P Kettunen","year":"2015","unstructured":"Kettunen P, Larsson S, Holmgren S, Olsson S, Minthon L, Zetterberg H, Blennow K, Nilsson S, Sj\u00f6lander A. Genetic variants of GSK3B are associated with biomarkers for Alzheimer\u2019s disease and cognitive function. J Alzheimers Dis. 2015;44(4):1313\u201322.","journal-title":"J Alzheimers Dis"},{"issue":"52","key":"211_CR66","doi-asserted-by":"crossref","first-page":"41340","DOI":"10.1074\/jbc.M006219200","volume":"275","author":"K Spittaels","year":"2000","unstructured":"Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, et al. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem. 2000;275(52):41340\u20139.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"211_CR67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","volume":"20","author":"JJ Lucas","year":"2001","unstructured":"Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 2001;20(1\u20132):27\u201339.","journal-title":"EMBO J"},{"issue":"5","key":"211_CR68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00001756-200404090-00021","volume":"15","author":"T Hansen","year":"2004","unstructured":"Hansen T, Rehfeld JF, Nielsen FC. GSK-3beta reduces cAMP-induced cholecystokinin gene expression by inhibiting CREB binding. NeuroReport. 2004;15(5):841\u20135.","journal-title":"NeuroReport"},{"issue":"4\u20135","key":"211_CR69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","volume":"32","author":"RS Jope","year":"2007","unstructured":"Jope RS, Yuskaitis CJ, Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res. 2007;32(4\u20135):577\u201395.","journal-title":"Neurochem Res"},{"issue":"46","key":"211_CR70","doi-asserted-by":"crossref","first-page":"33305","DOI":"10.1074\/jbc.M610390200","volume":"282","author":"M Townsend","year":"2007","unstructured":"Townsend M, Mehta T, Selkoe DJ. Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem. 2007;282(46):33305\u201312.","journal-title":"J Biol Chem"},{"issue":"14","key":"211_CR71","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1074\/jbc.M707108200","volume":"283","author":"MH Magdesian","year":"2008","unstructured":"Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, Juliano L, Garcia-Abreu J, Ferreira ST. Amyloid-beta binds to the extracellular cysteine- rich domain of Frizzled and inhibits Wnt\/beta-catenin signaling. J Biol Chem. 2008;283(14):9359\u201368.","journal-title":"J Biol Chem"},{"issue":"1","key":"211_CR72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2014.08.005","volume":"36","author":"J Yan","year":"2015","unstructured":"Yan J, Liu XH, Han MZ, Wang YM, Sun XL, Yu N, Li T, Su B, Chen ZY. Blockage of GSK3\u03b2-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer\u2019s disease. Neurobiol Aging. 2015;36(1):211\u201327.","journal-title":"Neurobiol Aging."},{"issue":"2","key":"211_CR73","first-page":"179","volume":"121","author":"K Imahori","year":"1997","unstructured":"Imahori K, Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer\u2019s disease. J Biochem. 1997;121(2):179\u201388.","journal-title":"J Biochem"},{"issue":"3","key":"211_CR74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuroscience.2004.07.036","volume":"129","author":"V Echeverria","year":"2004","unstructured":"Echeverria V, Ducatenzeiler A, Dowd E, Janne J, Grant SM, Szyf M, Wandosell F, Avila J, Grimm H, Dunnett SB, et al. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience. 2004;129(3):583\u201392.","journal-title":"Neuroscience"},{"issue":"6","key":"211_CR75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biopsych.2009.06.015","volume":"67","author":"J Espana","year":"2010","unstructured":"Espana J, Gimenez-Llort L, Valero J, Minano A, Rabano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer\u2019s disease transgenic mice. Biol Psychiatry. 2010;67(6):513\u201321.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"211_CR76","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-8993(93)91286-2","volume":"618","author":"JQ Trojanowski","year":"1993","unstructured":"Trojanowski JQ, Mawal-Dewan M, Schmidt ML, Martin J, Lee VM. Localization of the mitogen activated protein kinase ERK2 in Alzheimer\u2019s disease neurofibrillary tangles and senile plaque neurites. Brain Res. 1993;618(2):333\u20137.","journal-title":"Brain Res"},{"issue":"1\u20132","key":"211_CR77","first-page":"45","volume":"109","author":"JJ Pei","year":"2002","unstructured":"Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I. Up- regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer\u2019s disease. Brain Res Mol Brain Res. 2002;109(1\u20132):45\u201355.","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"211_CR78","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/35074516","volume":"3","author":"T Harada","year":"2001","unstructured":"Harada T, Morooka T, Ogawa S, Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol. 2001;3(5):453\u20139.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"211_CR79","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","volume":"68","author":"PP Roux","year":"2004","unstructured":"Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68(2):320\u201344.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"8","key":"211_CR80","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/MCB.24.8.3112-3124.2004","volume":"24","author":"M Pende","year":"2004","unstructured":"Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC, Thomas G. S6K1(\u2212\/\u2212)\/S6K2(\u2212\/\u2212) mice exhibit perinatal lethality and rapamycin-sensitive 5\u2032-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol. 2004;24(8):3112\u201324.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"211_CR81","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s007020100015","volume":"108","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gomez C, Ambrosio S. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK\/ERK), stress-activated protein kinase\/c-Jun N-terminal kinase (SAPK\/JNK), and p38 kinase expression in Parkinson\u2019s disease and Dementia with Lewy bodies. J Neural Transm. 2001;108(12):1383\u201396.","journal-title":"J Neural Transm"},{"issue":"12","key":"211_CR82","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s007020100016","volume":"108","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B. Phosphorylated mitogen-activated protein kinase (MAPK\/ERK-P), protein kinase of 38\u00a0kDa (p38-P), stress- activated protein kinase (SAPK\/JNK-P), and calcium\/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J Neural Transm. 2001;108(12):1397\u2013415.","journal-title":"J Neural Transm"},{"issue":"2\u20133","key":"211_CR83","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2004.10.011","volume":"1739","author":"KS Kosik","year":"2005","unstructured":"Kosik KS, Shimura H. Phosphorylated tau and the neurodegenerative foldopathies. Biochim Biophys Acta. 2005;1739(2\u20133):298\u2013310.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"211_CR84","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/MCB.25.1.278-293.2005","volume":"25","author":"SL Lambourne","year":"2005","unstructured":"Lambourne SL, Sellers LA, Bush TG, Choudhury SK, Emson PC, Suh YH, Wilkinson LS. Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer\u2019s disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities. Mol Cell Biol. 2005;25(1):278\u201393.","journal-title":"Mol Cell Biol"},{"issue":"6805","key":"211_CR85","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","volume":"407","author":"J Yuan","year":"2000","unstructured":"Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407(6805):802\u20139.","journal-title":"Nature"},{"issue":"6","key":"211_CR86","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1083\/jcb.200212017","volume":"160","author":"A Brown","year":"2003","unstructured":"Brown A. Axonal transport of membranous and nonmembranous cargoes: a unified perspective. J Cell Biol. 2003;160(6):817\u201321.","journal-title":"J Cell Biol"},{"issue":"3","key":"211_CR87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0197-4580(95)00026-B","volume":"16","author":"E Mandelkow","year":"1995","unstructured":"Mandelkow E, Song YH, Schweers O, Marx A, Mandelkow EM. On the structure of microtubules, tau, and paired helical filaments. Neurobiol Aging. 1995;16(3):347\u201354.","journal-title":"Neurobiol Aging"},{"key":"211_CR88","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-7091-6467-9_15","volume":"53","author":"K Iqbal","year":"1998","unstructured":"Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Transm Suppl. 1998;53:169\u201380.","journal-title":"J Neural Transm Suppl"},{"issue":"3","key":"211_CR89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000007969","volume":"40","author":"JP Brion","year":"1998","unstructured":"Brion JP. Neurofibrillary tangles and Alzheimer\u2019s disease. Eur Neurol. 1998;40(3):130\u201340.","journal-title":"Eur Neurol"},{"issue":"1","key":"211_CR90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/exnr.1998.7010","volume":"156","author":"TC Dickson","year":"1999","unstructured":"Dickson TC, King CE, McCormack GH, Vickers JC. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer\u2019s disease. Exp Neurol. 1999;156(1):100\u201310.","journal-title":"Exp Neurol"},{"issue":"2","key":"211_CR91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0301-0082(99)00023-4","volume":"60","author":"JC Vickers","year":"2000","unstructured":"Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G. The cause of neuronal degeneration in Alzheimer\u2019s disease. Prog Neurobiol. 2000;60(2):139\u201365.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"211_CR92","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(89)90582-X","volume":"103","author":"E Masliah","year":"1989","unstructured":"Masliah E, Terry RD, DeTeresa RM, Hansen LA. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett. 1989;103(2):234\u20139.","journal-title":"Neurosci Lett"},{"issue":"18","key":"211_CR93","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1523\/JNEUROSCI.16-18-05795.1996","volume":"16","author":"E Masliah","year":"1996","unstructured":"Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer\u2019s disease. J Neurosci. 1996;16(18):5795\u2013811.","journal-title":"J Neurosci"},{"issue":"3","key":"211_CR94","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1471-4159.2010.06643.x","volume":"113","author":"AG Henriques","year":"2010","unstructured":"Henriques AG, Vieira SI, da Cruz ESEF, da Cruz ESOA. Abeta promotes Alzheimer\u2019s disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J Neurochem. 2010;113(3):761\u201371.","journal-title":"J Neurochem"},{"issue":"6","key":"211_CR95","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2003.12.015","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak H, Del Tredici K. Alzheimer\u2019s disease: intraneuronal alterations precede insoluble amyloid-beta formation. Neurobiol Aging. 2004;25(6):713\u20138 (discussion 743\u2013716).","journal-title":"Neurobiol Aging"},{"issue":"3","key":"211_CR96","first-page":"823","volume":"19","author":"P Fernandez-Vizarra","year":"2004","unstructured":"Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, Martinez-Murillo R, Martinez A, Rodrigo J. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer\u2019s disease. Histol Histopathol. 2004;19(3):823\u201344.","journal-title":"Histol Histopathol"},{"issue":"5534","key":"211_CR97","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293(5534):1487\u201391.","journal-title":"Science"},{"issue":"1","key":"211_CR98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","volume":"25","author":"A Mudher","year":"2002","unstructured":"Mudher A, Lovestone S. Alzheimer\u2019s disease-do tauists and baptists finally shake hands? Trends Neurosci. 2002;25(1):22\u20136.","journal-title":"Trends Neurosci"},{"issue":"28","key":"211_CR99","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signalling: suppression by omega-3 fatty acids and curcumin. J Neurosci. 2009;29(28):9078\u201389.","journal-title":"J Neurosci"},{"issue":"5534","key":"211_CR100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001;293(5534):1491\u20135.","journal-title":"Science"},{"issue":"2","key":"211_CR101","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9440(10)63997-1","volume":"158","author":"T Ishihara","year":"2001","unstructured":"Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol. 2001;158(2):555\u201362.","journal-title":"Am J Pathol"},{"issue":"9","key":"211_CR102","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnen\/59.9.751","volume":"59","author":"AM Saunders","year":"2000","unstructured":"Saunders AM. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol. 2000;59(9):751\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"211_CR103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","volume":"135","author":"T Wisniewski","year":"1992","unstructured":"Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135(2):235\u20138.","journal-title":"Neurosci Lett"},{"issue":"2","key":"211_CR104","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/exnr.1996.0064","volume":"138","author":"LM Fleming","year":"1996","unstructured":"Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp Neurol. 1996;138(2):252\u201360.","journal-title":"Exp Neurol"},{"issue":"17","key":"211_CR105","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1074\/jbc.M112.411900","volume":"288","author":"S Ly","year":"2013","unstructured":"Ly S, Altman R, Petrlova J, Lin Y, Hilt S, Huser T, Laurence TA, Voss JC. Binding of apolipoprotein E inhibits the oligomer growth of amyloid-beta peptide in solution as determined by fluorescence cross-correlation spectroscopy. J Biol Chem. 2013;288(17):11628\u201335.","journal-title":"J Biol Chem"},{"issue":"2","key":"211_CR106","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/07853890009011761","volume":"32","author":"JD Smith","year":"2000","unstructured":"Smith JD. Apolipoprotein E4: an allele associated with many diseases. Ann Med. 2000;32(2):118\u201327.","journal-title":"Ann Med"},{"key":"211_CR107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1749-6632.2000.tb06365.x","volume":"903","author":"MJ Ladu","year":"2000","unstructured":"Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, Holtzman D, Getz GS. Lipoproteins in the central nervous system. Ann N Y Acad Sci. 2000;903:167\u201375.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"211_CR108","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.1134","volume":"50","author":"DB Carter","year":"2001","unstructured":"Carter DB, Dunn E, McKinley DD, Stratman NC, Boyle TP, Kuiper SL, Oostveen JA, Weaver RJ, Boller JA, Gurney ME. Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. Ann Neurol. 2001;50(4):468\u201375.","journal-title":"Ann Neurol"},{"issue":"3","key":"211_CR109","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-2275(20)31662-X","volume":"42","author":"KH Cho","year":"2001","unstructured":"Cho KH, Durbin DM, Jonas A. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin: cholesterol acyltransferase and in HDL rearrangements. J Lipid Res. 2001;42(3):379\u201389.","journal-title":"J Lipid Res"},{"issue":"2\u20133","key":"211_CR110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","volume":"130","author":"S Varadarajan","year":"2000","unstructured":"Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Alzheimer\u2019s amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol. 2000;130(2\u20133):184\u2013208.","journal-title":"J Struct Biol"},{"issue":"12","key":"211_CR111","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","volume":"36","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review. Free Radic Res. 2002;36(12):1307\u201313.","journal-title":"Free Radic Res"},{"issue":"3","key":"211_CR112","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2002-4309","volume":"4","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Griffin S, Munch G, Pasinetti GM. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer\u2019s disease brain exists. J Alzheimers Dis. 2002;4(3):193\u2013201.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"211_CR113","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jnr.10389","volume":"70","author":"R Castellani","year":"2002","unstructured":"Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer\u2019s disease. J Neurosci Res. 2002;70(3):357\u201360.","journal-title":"J Neurosci Res"},{"key":"211_CR114","doi-asserted-by":"crossref","first-page":"324968","DOI":"10.1155\/2012\/324968","volume":"2012","author":"C Spuch","year":"2012","unstructured":"Spuch C, Ortolano S, Navarro C. New insights in the amyloid-Beta interaction with mitochondria. J Aging Res. 2012;2012:324968.","journal-title":"J Aging Res"},{"issue":"1","key":"211_CR115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol. 2003;161(1):41\u201354.","journal-title":"J Cell Biol"},{"issue":"6","key":"211_CR116","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0301-0082(00)00015-0","volume":"62","author":"S Miranda","year":"2000","unstructured":"Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, Inestrosa NC. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer\u2019s disease. Prog Neurobiol. 2000;62(6):633\u201348.","journal-title":"Prog Neurobiol"},{"issue":"4","key":"211_CR117","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000022156","volume":"46","author":"M DiCiero Miranda","year":"2000","unstructured":"DiCiero Miranda M, de Bruin VM, Vale MR, Viana GS. Lipid peroxidation and nitrite plus nitrate levels in brain tissue from patients with Alzheimer\u2019s disease. Gerontology. 2000;46(4):179\u201384.","journal-title":"Gerontology"},{"issue":"Suppl 2","key":"211_CR118","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","volume":"20","author":"N Dragicevic","year":"2010","unstructured":"Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer\u2019s transgenic mice. J Alzheimers Dis. 2010;20(Suppl 2):S535\u201350.","journal-title":"J Alzheimers Dis"},{"key":"211_CR119","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","volume":"83","author":"A Lloret","year":"2015","unstructured":"Lloret A, Fuchsberger T, Giraldo E, Vina J. Molecular mechanisms linking amyloid \u03b2 toxicity and Tau hyperphosphorylation in Alzheimer\u2019s disease. Free Radic Biol Med. 2015;83:186\u201391.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"211_CR120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","volume":"96","author":"PH Reddy","year":"2006","unstructured":"Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer\u2019s disease. J Neurochem. 2006;96(1):1\u201313.","journal-title":"J Neurochem"},{"issue":"8","key":"211_CR121","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","volume":"27","author":"TI Williams","year":"2006","unstructured":"Williams TI, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer\u2019s disease. Neurobiol Aging. 2006;27(8):1094\u20139.","journal-title":"Neurobiol Aging"},{"issue":"1613","key":"211_CR122","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2015.04.007","volume":"10","author":"F Marmol","year":"2015","unstructured":"Marmol F, Rodriguez CA, Sanchez J, Chamizo VD. Anti-oxidative effects produced by environmental enrichment in the hippocampus and cerebral cortex of male and female rats. Brain Res. 2015;10(1613):120\u20139.","journal-title":"Brain Res"},{"issue":"9","key":"211_CR123","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0047-6374(01)00249-4","volume":"122","author":"DA Butterfield","year":"2001","unstructured":"Butterfield DA, Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev. 2001;122(9):945\u201362.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"211_CR124","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","volume":"75","author":"JN Keller","year":"2000","unstructured":"Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer\u2019s disease. J Neurochem. 2000;75(1):436\u20139.","journal-title":"J Neurochem"},{"issue":"10","key":"211_CR125","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/PL00000787","volume":"58","author":"R Shringarpure","year":"2001","unstructured":"Shringarpure R, Grune T, Davies KJ. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells. Cell Mol Life Sci. 2001;58(10):1442\u201350.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"211_CR126","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9343(00)00547-7","volume":"109","author":"D Pratico","year":"2000","unstructured":"Pratico D, Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer\u2019s disease. Am J Med. 2000;109(7):577\u201385.","journal-title":"Am J Med"},{"issue":"11","key":"211_CR127","first-page":"1586","volume":"57","author":"GA Broe","year":"2000","unstructured":"Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bennett HP, Brooks WS, Halliday GM. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol. 2000;57(11):1586\u201391.","journal-title":"Arch Neurol"},{"issue":"6","key":"211_CR128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0197-4580(00)00219-0","volume":"21","author":"Q Wu","year":"2000","unstructured":"Wu Q, Combs C, Cannady SB, Geldmacher DS, Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol Aging. 2000;21(6):797\u2013806.","journal-title":"Neurobiol Aging"},{"issue":"5\u20136","key":"211_CR129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0197-0186(01)00045-6","volume":"39","author":"EN Benveniste","year":"2001","unstructured":"Benveniste EN, Nguyen VT, O\u2019Keefe GM. Immunological aspects of microglia: relevance to Alzheimer\u2019s disease. Neurochem Int. 2001;39(5\u20136):381\u201391.","journal-title":"Neurochem Int"},{"issue":"1","key":"211_CR130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(00)00404-5","volume":"113","author":"AM Szczepanik","year":"2001","unstructured":"Szczepanik AM, Funes S, Petko W, Ringheim GE. IL-4, IL-10 and IL-13 modulate A beta(1\u201342)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol. 2001;113(1):49\u201362.","journal-title":"J Neuroimmunol"},{"issue":"Suppl 1","key":"211_CR131","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00002093-200000001-00008","volume":"14","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord. 2000;14(Suppl 1):S47\u201353.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"211_CR132","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/1097-4547(20000715)61:2<128::AID-JNR2>3.0.CO;2-H","volume":"61","author":"AK Raina","year":"2000","unstructured":"Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA. Cyclin\u2019 toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res. 2000;61(2):128\u201333.","journal-title":"J Neurosci Res"},{"issue":"8\u20139","key":"211_CR133","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s007020050104","volume":"105","author":"T Arendt","year":"1998","unstructured":"Arendt T, Holzer M, Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer\u2019s disease. J Neural Transm. 1998;105(8\u20139):949\u201360.","journal-title":"J Neural Transm"},{"issue":"8","key":"211_CR134","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1523\/JNEUROSCI.18-08-02801.1998","volume":"18","author":"J Busser","year":"1998","unstructured":"Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer\u2019s disease brain. J Neurosci. 1998;18(8):2801\u20137.","journal-title":"J Neurosci"},{"issue":"27","key":"211_CR135","doi-asserted-by":"crossref","first-page":"19011","DOI":"10.1074\/jbc.274.27.19011","volume":"274","author":"A Giovanni","year":"1999","unstructured":"Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F\u00a0\u00d7\u00a0DP, B-amyloid-induced neuronal death. J Biol Chem. 1999;274(27):19011\u20136.","journal-title":"J Biol Chem"},{"issue":"8","key":"211_CR136","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1523\/JNEUROSCI.21-08-02661.2001","volume":"21","author":"Y Yang","year":"2001","unstructured":"Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer\u2019s disease. J Neurosci. 2001;21(8):2661\u20138.","journal-title":"J Neurosci"},{"issue":"7","key":"211_CR137","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1523\/JNEUROSCI.23-07-02557.2003","volume":"23","author":"Y Yang","year":"2003","unstructured":"Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer\u2019s disease. J Neurosci. 2003;23(7):2557\u201363.","journal-title":"J Neurosci"},{"issue":"2","key":"211_CR138","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2613.1999.00106.x","volume":"80","author":"AK Raina","year":"1999","unstructured":"Raina AK, Monteiro MJ, McShea A, Smith MA. The role of cell cycle-mediated events in Alzheimer\u2019s disease. Int J Exp Pathol. 1999;80(2):71\u20136.","journal-title":"Int J Exp Pathol"},{"issue":"4\u20135","key":"211_CR139","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0736-5748(00)00010-1","volume":"18","author":"X Zhu","year":"2000","unstructured":"Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA. Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci. 2000;18(4\u20135):433\u20137.","journal-title":"Int J Dev Neurosci"},{"issue":"15","key":"211_CR140","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1096\/fasebj.13.15.2225","volume":"13","author":"A Copani","year":"1999","unstructured":"Copani A, Condorelli F, Caruso A, Vancheri C, Sala A, Giuffrida Stella AM, Canonico PL, Nicoletti F, Sortino MA. Mitotic signaling by beta-amyloid causes neuronal death. FASEB J. 1999;13(15):2225\u201334.","journal-title":"FASEB J"},{"issue":"1","key":"211_CR141","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(00)01663-5","volume":"24","author":"A Copani","year":"2001","unstructured":"Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci. 2001;24(1):25\u201331.","journal-title":"Trends Neurosci"},{"key":"211_CR142","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.brainres.2008.04.050","volume":"1218","author":"S Majd","year":"2008","unstructured":"Majd S, Zarifkar A, Rastegar K, Takhshid MA. Different fibrillar Abeta 1-42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle. Brain Res. 2008;1218:224\u20139.","journal-title":"Brain Res"},{"issue":"3","key":"211_CR143","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9440(10)63347-0","volume":"165","author":"M Zhang","year":"2004","unstructured":"Zhang M, Li J, Chakrabarty P, Bu B, Vincent I. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am J Pathol. 2004;165(3):843\u201353.","journal-title":"Am J Pathol"},{"issue":"1","key":"211_CR144","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12640-012-9330-y","volume":"23","author":"S Majd","year":"2013","unstructured":"Majd S, Chegini F, Chataway T, Zhou XF, Gai W. Reciprocal induction between alpha-synuclein and beta-amyloid in adult rat neurons. Neurotox Res. 2013;23(1):69\u201378.","journal-title":"Neurotox Res"},{"issue":"3","key":"211_CR145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1582-4934.2005.tb00485.x","volume":"9","author":"Z Nagy","year":"2005","unstructured":"Nagy Z. The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer\u2019s disease. J Cell Mol Med. 2005;9(3):531\u201341.","journal-title":"J Cell Mol Med"},{"key":"211_CR146","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neurobiolaging.2013.11.019","volume":"35","author":"CC Tan","year":"2014","unstructured":"Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging. 2014;35:941\u201357.","journal-title":"Neurobiol Aging"},{"issue":"6645","key":"211_CR147","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340.","journal-title":"Nature"},{"issue":"6","key":"211_CR148","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med. 2002;8(6):600\u20136.","journal-title":"Nat Med"},{"issue":"3","key":"211_CR149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS. Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol. 1996;55(3):259\u201372.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"211_CR150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164\u201373.","journal-title":"Ann Neurol"},{"issue":"2","key":"211_CR151","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 1995;15(2):361\u201372.","journal-title":"Neuron"},{"issue":"2","key":"211_CR152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008;5(2):55\u20139.","journal-title":"Neurodegener Dis"},{"issue":"1","key":"211_CR153","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2002.7929","volume":"176","author":"F Mori","year":"2002","unstructured":"Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K. Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol. 2002;176(1):98\u2013104.","journal-title":"Exp Neurol"},{"issue":"6","key":"211_CR154","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.03-0338rev","volume":"18","author":"A Recchia","year":"2004","unstructured":"Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P. Alpha-synuclein and Parkinson\u2019s disease. FASEB J. 2004;18(6):617\u201326.","journal-title":"FASEB J"},{"issue":"44","key":"211_CR155","doi-asserted-by":"crossref","first-page":"34393","DOI":"10.1074\/jbc.M004851200","volume":"275","author":"RJ Perrin","year":"2000","unstructured":"Perrin RJ, Woods WS, Clayton DF, George JM. Interaction of human alpha-Synuclein and Parkinson\u2019s disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J Biol Chem. 2000;275(44):34393\u20138.","journal-title":"J Biol Chem"},{"issue":"20","key":"211_CR156","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci. 2002;22(20):8797\u2013807.","journal-title":"J Neurosci"},{"issue":"3","key":"211_CR157","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005;123(3):383\u201396.","journal-title":"Cell"},{"issue":"46","key":"211_CR158","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1523\/JNEUROSCI.3821-06.2006","volume":"26","author":"KE Larsen","year":"2006","unstructured":"Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH, et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci. 2006;26(46):11915\u201322.","journal-title":"J Neurosci"},{"issue":"5999","key":"211_CR159","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329(5999):1663\u20137.","journal-title":"Science"},{"issue":"3","key":"211_CR160","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1074\/jbc.M102981200","volume":"277","author":"MA Alim","year":"2002","unstructured":"Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M, Kaji H, Shinoda T, Hisanaga S, Ueda K. Tubulin seeds alpha-synuclein fibril formation. J Biol Chem. 2002;277(3):2112\u20137.","journal-title":"J Biol Chem"},{"issue":"4","key":"211_CR161","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-2004-6412","volume":"6","author":"MA Alim","year":"2004","unstructured":"Alim MA, Ma QL, Takeda K, Aizawa T, Matsubara M, Nakamura M, Asada A, Saito T, Kaji H, Yoshii M, et al. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J Alzheimers Dis. 2004;6(4):435\u201342 (discussion 443\u2013439).","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"211_CR162","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1007\/s11033-009-9899-2","volume":"37","author":"RM Zhou","year":"2010","unstructured":"Zhou RM, Huang YX, Li XL, Chen C, Shi Q, Wang GR, Tian C, Wang ZY, Jing YY, Gao C, et al. Molecular interaction of alpha-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells. Mol Biol Rep. 2010;37(7):3183\u201392.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"211_CR163","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160\u20134.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"211_CR164","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","volume":"103","author":"VN Uversky","year":"2007","unstructured":"Uversky VN. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem. 2007;103(1):17\u201337.","journal-title":"J Neurochem"},{"key":"211_CR165","doi-asserted-by":"crossref","first-page":"e1004302","DOI":"10.1371\/journal.pgen.1004302","volume":"10","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro S, Reimao-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D, Rosado-Ramos R, Amen T, Waiss M, Magalhaes F, et al. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson\u2019s disease. PLoS Genet. 2014;10:e1004302.","journal-title":"PLoS Genet."},{"issue":"11","key":"211_CR166","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","volume":"23","author":"AL Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier AL, Fauvet B, Gysbers A, Dikiy I, Oueslati A, Georgeon S, Lamontanara AJ, Bisquertt A, Eliezer D, Masliah E, et al. c-Abl phosphorylates alpha-synuclein and regulates its degradation, implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson\u2019s Disease. Hum Mol Genet. 2014;23(11):2858\u201379.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"211_CR167","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)00297-5","volume":"326","author":"W Tamo","year":"2002","unstructured":"Tamo W, Imaizumi T, Tanji K, Yoshida H, Mori F, Yoshimoto M, Takahashi H, Fukuda I, Wakabayashi K, Satoh K. Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer\u2019s disease amyloid, in human cerebral blood vessels. Neurosci Lett. 2002;326(1):5\u20138.","journal-title":"Neurosci Lett"},{"issue":"4","key":"211_CR168","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1371\/journal.pone.0001867","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ. Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One. 2008;3(4):e1867.","journal-title":"PLoS One"},{"issue":"Pt 3","key":"211_CR169","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1042\/bj3400821","volume":"340","author":"SR Paik","year":"1999","unstructured":"Paik SR, Shin HJ, Lee JH, Chang CS, Kim J. Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem J. 1999;340(Pt 3):821\u20138.","journal-title":"Biochem J"},{"issue":"4","key":"211_CR170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","volume":"10","author":"M Hashimoto","year":"1999","unstructured":"Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E. Oxidative stress induces amyloid-like aggregate formation of NACP\/alpha-synuclein in vitro. Neuroreport. 1999;10(4):717\u201321.","journal-title":"Neuroreport"},{"issue":"9","key":"211_CR171","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci. 2000;20(9):3214\u201320.","journal-title":"J Neurosci"},{"issue":"41","key":"211_CR172","doi-asserted-by":"crossref","first-page":"40186","DOI":"10.1074\/jbc.M305326200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu M, Li J, Fink AL. The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem. 2003;278(41):40186\u201397.","journal-title":"J Biol Chem"},{"issue":"15","key":"211_CR173","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/j.1432-1033.2004.04250.x","volume":"271","author":"E Jo","year":"2004","unstructured":"Jo E, Darabie AA, Han K, Tandon A, Fraser PE, McLaurin J. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis. Eur J Biochem. 2004;271(15):3180\u20139.","journal-title":"Eur J Biochem"},{"issue":"30","key":"211_CR174","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott D, Roy S. alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J Neurosci. 2012;32(30):10129\u201335.","journal-title":"J Neurosci"},{"key":"211_CR175","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, McLean PJ, Unni VK. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of \u03b1- synuclein. J Neurosci. 2011;31:14508\u201320.","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"211_CR176","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/S1353-8020(13)70037-3","volume":"20","author":"PY Pan","year":"2014","unstructured":"Pan PY, Yue Z. Genetic causes of Parkinson\u2019s disease and their links to autophagy regulation. Parkinsonism Relat Disord. 2014;20(Suppl 1):S154\u20137.","journal-title":"Parkinsonism Relat Disord."},{"issue":"1","key":"211_CR177","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1471-4159.2001.t01-1-00232.x","volume":"77","author":"A Iwata","year":"2001","unstructured":"Iwata A, Miura S, Kanazawa I, Sawada M, Nukina N. alpha-Synuclein forms a complex with transcription factor Elk-1. J Neurochem. 2001;77(1):239\u201352.","journal-title":"J Neurochem"},{"issue":"6","key":"211_CR178","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1096\/fj.03-1112rev","volume":"18","author":"A Sidhu","year":"2004","unstructured":"Sidhu A, Wersinger C, Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J. 2004;18(6):637\u201347.","journal-title":"FASEB J"},{"issue":"48","key":"211_CR179","doi-asserted-by":"crossref","first-page":"45320","DOI":"10.1074\/jbc.M103736200","volume":"276","author":"A Iwata","year":"2001","unstructured":"Iwata A, Maruyama M, Kanazawa I, Nukina N. alpha-Synuclein affects the MAPK pathway and accelerates cell death. J Biol Chem. 2001;276(48):45320\u20139.","journal-title":"J Biol Chem"},{"issue":"20","key":"211_CR180","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddg283","volume":"12","author":"A Iwata","year":"2003","unstructured":"Iwata A, Maruyama M, Akagi T, Hashikawa T, Kanazawa I, Tsuji S, Nukina N. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. Hum Mol Genet. 2003;12(20):2625\u201335.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"211_CR181","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","volume":"101","author":"S Hunot","year":"2004","unstructured":"Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2004;101(2):665\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"211_CR182","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","volume":"19","author":"N Ostrerova","year":"1999","unstructured":"Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci. 1999;19(14):5782\u201391.","journal-title":"J Neurosci"},{"issue":"4","key":"211_CR183","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps. Apoptosis. 2009;14(4):478\u2013500.","journal-title":"Apoptosis"},{"issue":"9","key":"211_CR184","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1096\/fj.06-7580com","volume":"21","author":"S Karunakaran","year":"2007","unstructured":"Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S, Ravindranath V. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson\u2019s disease: protection by alpha-lipoic acid. FASEB J. 2007;21(9):2226\u201336.","journal-title":"FASEB J"},{"issue":"5","key":"211_CR185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","volume":"29","author":"A Klegeris","year":"2008","unstructured":"Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, McGeer PL. Alpha-synuclein activates stress signalling protein kinases in THP-1 cells and microglia. Neurobiol Aging. 2008;29(5):739\u201352.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"211_CR186","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/039463200902200405","volume":"22","author":"H Wilms","year":"2009","unstructured":"Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schafer H, Seegert D, Kahle PJ, Odoy S, Claasen JH, Holzknecht C, et al. Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils. Int J Immunopathol Pharmacol. 2009;22(4):897\u2013909.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"7","key":"211_CR187","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/cns.12264","volume":"20","author":"A Camilleri","year":"2014","unstructured":"Camilleri A, Vassallo N. The centrality of mitochondria in the pathogenesis and treatment of Parkinson\u2019s disease. CNS Neurosci Ther. 2014;20(7):591\u2013602.","journal-title":"CNS Neurosci Ther."},{"issue":"6","key":"211_CR188","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00109-013-1038-9","volume":"91","author":"SE Eisbach","year":"2013","unstructured":"Eisbach SE, Outeiro TF. Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson\u2019s disease pathology. J Mol Med (Berl). 2013;91(6):693\u2013703.","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"211_CR189","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD. Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 1994;36(3):348\u201355.","journal-title":"Ann Neurol"},{"issue":"6","key":"211_CR190","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem. 1989;52(6):1830\u20136.","journal-title":"J Neurochem"},{"issue":"4","key":"211_CR191","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","volume":"86","author":"MB Spina","year":"1989","unstructured":"Spina MB, Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Natl Acad Sci USA. 1989;86(4):1398\u2013400.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"211_CR192","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E. alpha-Synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol. 2000;157(2):401\u201310.","journal-title":"Am J Pathol"},{"issue":"15","key":"211_CR193","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/WNR.0b013e3282f03db4","volume":"18","author":"WW Li","year":"2007","unstructured":"Li WW, Yang R, Guo JC, Ren HM, Zha XL, Cheng JS, Cai DF. Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport. 2007;18(15):1543\u20136.","journal-title":"Neuroreport"},{"issue":"7\u20138","key":"211_CR194","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","volume":"65","author":"MS Parihar","year":"2008","unstructured":"Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P. Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci. 2008;65(7\u20138):1272\u201384.","journal-title":"Cell Mol Life Sci"},{"issue":"24","key":"211_CR195","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","volume":"33","author":"D Dryanovski","year":"2013","unstructured":"Dryanovski D, Guzman J, Xie Z, Galteri D, Volpicelli-Daley L, Lee V, Miller R, Schumacker P, Surmeier D. Calcium entry and \u03b1-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J Neurosci. 2013;33(24):10154\u201364.","journal-title":"J Neurosci"},{"key":"211_CR196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/108029","volume":"108029","author":"M Zaltieri","year":"2015","unstructured":"Zaltieri M, Longhena F, Pizzi M, Missale C, Spano P, Bellucci A. Mitochondrial Dysfunction and \u03b1-synuclein Synaptic Pathology in Parkinson\u2019s Disease: Who\u2019s on First. Parkinsons Dis. 2015;108029:1\u201310.","journal-title":"Parkinsons Dis."},{"issue":"1","key":"211_CR197","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","volume":"86","author":"X Liu","year":"1996","unstructured":"Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86(1):147\u201357.","journal-title":"Cell"},{"issue":"11","key":"211_CR198","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1091\/mbc.E09-09-0801","volume":"21","author":"N Thayanidhi","year":"2010","unstructured":"Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang Y, Hay JC. Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs. Mol Biol Cell. 2010;21(11):1850\u201363.","journal-title":"Mol Biol Cell"},{"issue":"10","key":"211_CR199","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK. Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J Neurosci. 2012;32(10):3301\u20135.","journal-title":"J Neurosci"},{"issue":"2","key":"211_CR200","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","volume":"278","author":"PG Foran","year":"2003","unstructured":"Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, Smith L, Aoki KR, Dolly JO. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem. 2003;278(2):1363\u201371.","journal-title":"J Biol Chem"},{"issue":"3","key":"211_CR201","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbrc.2007.02.163","volume":"356","author":"L Chen","year":"2007","unstructured":"Chen L, Jin J, Davis J, Zhou Y, Wang Y, Liu J, Lockhart PJ, Zhang J. Oligomeric alpha-synuclein inhibits tubulin polymerization. Biochem Biophys Res Commun. 2007;356(3):548\u201353.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"211_CR202","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1091\/mbc.E07-08-0827","volume":"19","author":"JH Soper","year":"2008","unstructured":"Soper JH, Roy S, Stieber A, Lee E, Wilson RB, Trojanowski JQ, Burd CG, Lee VM. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell. 2008;19(3):1093\u2013103.","journal-title":"Mol Biol Cell"},{"issue":"50","key":"211_CR203","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1074\/jbc.M208194200","volume":"277","author":"N Gosavi","year":"2002","unstructured":"Gosavi N, Lee HJ, Lee JS, Patel S, Lee SJ. Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J Biol Chem. 2002;277(50):48984\u201392.","journal-title":"J Biol Chem"},{"issue":"11","key":"211_CR204","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1111\/j.1460-9568.2006.05210.x","volume":"24","author":"HJ Lee","year":"2006","unstructured":"Lee HJ, Khoshaghideh F, Lee S, Lee SJ. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Eur J Neurosci. 2006;24(11):3153\u201362.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"211_CR205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010;65(1):66\u201379.","journal-title":"Neuron"},{"issue":"Pt 7","key":"211_CR206","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/jcs.00967","volume":"117","author":"AR Saha","year":"2004","unstructured":"Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AM, Buchman VL, Anderton BH, et al. Parkinson\u2019s disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci. 2004;117(Pt 7):1017\u201324.","journal-title":"J Cell Sci"},{"issue":"23","key":"211_CR207","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K Ueda","year":"1993","unstructured":"Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA. 1993;90(23):11282\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"211_CR208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","volume":"145","author":"S Yu","year":"2007","unstructured":"Yu S, Li X, Liu G, Han J, Zhang C, Li Y, Xu S, Liu C, Gao Y, Yang H, et al. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience. 2007;145(2):539\u201355.","journal-title":"Neuroscience"},{"issue":"Pt 4","key":"211_CR209","first-page":"1093","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, Allsop D, Hassan AH, Jensen PH, El-Agnaf OM. Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain. 2009;132(Pt 4):1093\u2013101.","journal-title":"Brain"},{"issue":"3","key":"211_CR210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1523\/JNEUROSCI.3707-05.2006","volume":"26","author":"Y Yang","year":"2006","unstructured":"Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer\u2019s disease and amyloid precursor protein transgenic mouse models. J Neurosci. 2006;26(3):775\u201384.","journal-title":"J Neurosci"},{"issue":"3","key":"211_CR211","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","volume":"11","author":"G Gallardo","year":"2008","unstructured":"Gallardo G, Schluter OM, Sudhof TC. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Nat Neurosci. 2008;11(3):301\u20138.","journal-title":"Nat Neurosci"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-015-0211-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T23:32:21Z","timestamp":1718148741000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2202\/16\/69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":211,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1186\/s12868-015-0211-1","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]},"article-number":"69"}}